WAYNE, Pa.--(BUSINESS WIRE)--Oct. 28, 2015--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, is committed to connecting
clinicians with technology in a way that improves clinical practice and
advances patient outcomes. Teleflex will showcase its broad portfolio of
products for the field of emergency medicine at the ERC European
Resuscitation Council, to be held in Prague, Czech Republic on October
29-31, 2015.
During the event, Teleflex will highlight its range of innovative
solutions for intraosseous vascular access, rescue airway, atomization
and intubation needs. This includes the Arrow® EZ-IO®
Intraosseous Vascular Access System, the LMA Supreme® Airway,
as well as the LMA® MAD Nasal™ Intranasal Mucosal Atomization
Device. Teleflex will also be hosting several in-booth scenario
workshops.
The Arrow® EZ-IO® Intraosseous Vascular Access
System from Teleflex is a complete solution for rapid vascular access –
whether the emergency responder is facing difficult vascular access
challenges or the need for fast intraosseous access for critical
situations and life-threatening emergencies. This system is designed to
provide the medical professional vascular access to the central
circulation system within seconds1, delivering medications,
intravenous fluids and blood products to adult and pediatric patients
alike.
The LMA Supreme® Airway is a laryngeal mask offering a safe
and effective option for establishing an emergency airway. Featuring a
built-in drain tube to channel gastric secretions away from the airway,
the LMA Supreme® Airway is an ideal choice for patients
undergoing certain procedures requiring mechanical ventilation in the
field.
Another featured product will be the LMA® MAD Nasal™
Intranasal Mucosal Atomization Device from Teleflex. When IV drug
delivery is less than ideal the LMA® MAD Nasal™ Device2
can come to the rescue delivering safe, painless and rapidly effective
treatment. No needle. No trauma. No risk of needle stick injury.
The Teleflex Clinical & Medical Affairs team will be on hand to conduct
scenario based resuscitation scenarios on high fidelity simulation
models. The team of highly experienced clinicians from across Europe and
the United States will lead scenarios focusing on providing the latest,
evidence based interventions related to intraosseous needle placement,
intranasal medication delivery, supraglottic airway placement, direct as
well as video laryngoscopy. These interactive sessions will help educate
clinicians from around Europe, advancing clinical practice and improving
patient outcomes.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rusch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI, LMA,
LMA Supreme, MAD Nasal, Pilling, and Weck are trademarks or registered
trademarks of Teleflex Incorporated or its affiliates, in the U.S.
and/or other countries. © 2015 Teleflex Incorporated. All rights
reserved.
References:
1. Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does intraosseous equal
intravenous? A pharmacokinetic study. Amer J Emerg Med 2008;26:31-8
2. For use with drugs approved for intranasal delivery
View source version on businesswire.com: http://www.businesswire.com/news/home/20151028005047/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
or
Martina
Teichmann-Zindler
Director Marketing Communications International
+49
(0)7151-406-538
martina.teichmann@teleflex.com